Because of a statistical error in a recent study, the firm reduced test performance numbers, but it noted that the revised numbers are still far better than standard histopathology.
They have begun clinical testing of a table-top centrifuge and microfluidic chip that efficiently separated exosomes and enabled testing for disease markers in an internal study.
The researchers said that their reagent, which makes TB cells emit light, could be integrated into slide-and-microscope testing platforms.
The researchers said that a study to validate their concept showed that the platform has potential to detect cancer and infectious disease biomarkers in human blood.
Guidance for 2018 placements of ePlex respiratory testing systems is lower than analysts’ estimates, but the firm communicated remedies for adoption challenges.
As a clinical study seeks to decide whether low levels of PCT can guide antibiotic therapy, researchers are exploring alternate, gene expression biomarkers.
A broad team of researchers has developed a microarray that looks for 171,000 different peptide fragments to differentiate among tick-borne diseases.
The firm has licensed its test to Abbott, BioMérieux, and Quanterix, and it is working with the US Department of Defense as part of a collaborative approach.
In a first clinical tryout, University of Turku researchers have shown that their assay has sensitivity and specificity levels on par with those of laboratory ELISAs.
Three independent studies have shown that an α-synuclein assay technology detected early Parkinson's with high levels of sensitivity and specificity.